These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6800076)

  • 21. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].
    Wu C
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683
    [No Abstract]   [Full Text] [Related]  

  • 22. Immune responses to polysaccharides: lessons from humans and mice.
    González-Fernández A; Faro J; Fernández C
    Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vaccines against Neisseria meningitidis].
    Ferrón L; Criado MT; Ferreirós CM
    Enferm Infecc Microbiol Clin; 1992 May; 10(5):296-301. PubMed ID: 1391002
    [No Abstract]   [Full Text] [Related]  

  • 24. Responses to tuberculin and meningococcal polysaccharide vaccination during ageing in Nigerians.
    Oyeyinka GO; Salimonu LS; Balogun B; Idowu JR
    Ann Trop Med Parasitol; 1995 Jun; 89(3):317-20. PubMed ID: 7668925
    [No Abstract]   [Full Text] [Related]  

  • 25. The duration of the antibody response to meningococcal vaccination in an African village.
    Greenwood BM; Whittle HC; Bradley AK; Fayet MT; Gilles HM
    Trans R Soc Trop Med Hyg; 1980; 74(6):756-60. PubMed ID: 6782720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revaccination with polyvalent pneumococcal vaccine in children with sickle cell anemia.
    Kaplan J; Sarnaik S; Schiffman G
    Am J Pediatr Hematol Oncol; 1986; 8(1):80-2. PubMed ID: 3717518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are sickle cell anaemia and sickle cell trait predictive factors for periodontal disease? A cohort study.
    de Carvalho HL; Thomaz EB; Alves CM; Souza SF
    J Periodontal Res; 2016 Oct; 51(5):622-9. PubMed ID: 26670655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody response of adults to an aluminum hydroxide-adsorbed Neisseria meningitidis serotype 2b protein-group B polysaccharide vaccine.
    Frasch CE; Zahradnik JM; Wang LY; Mocca LF; Tsai CM
    J Infect Dis; 1988 Oct; 158(4):710-8. PubMed ID: 3139776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of dose to the reactogenicity and immunogenicity of meningococcal polysaccharide vaccines in adults.
    Griffiss JM; Brandt BL; Broud DD; Altieri PL; Berman SL
    Mil Med; 1985 Oct; 150(10):529-33. PubMed ID: 3934585
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased in vivo activation of neutrophils and complement in sickle cell disease.
    Mohamed AO; Hashim MS; Nilsson UR; Venge P
    Am J Trop Med Hyg; 1993 Dec; 49(6):799-803. PubMed ID: 8279646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Observations on the reactions and preventive efficacy of lyophilized group A meningococcal polysaccharide vaccine (author's transl)].
    Song BH; Liu DG
    Zhonghua Yu Fang Yi Xue Za Zhi; 1982 Jan; 16(1):39-41. PubMed ID: 6807642
    [No Abstract]   [Full Text] [Related]  

  • 32. Sickle cell trait and Plasmodium falciparum parasitaemia in pregnancy in Western Province, Kenya.
    Brabin BJ; Perrin L
    Trans R Soc Trop Med Hyg; 1985; 79(5):733. PubMed ID: 4095754
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
    Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
    Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial.
    Lieberman JM; Chiu SS; Wong VK; Partidge S; Chang SJ; Chiu CY; Gheesling LL; Carlone GM; Ward JI
    JAMA; 1996 May; 275(19):1499-503. PubMed ID: 8622225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A potential polyvalent Neisseria meningitidis vaccine based on a mixture of CaCl2 cell extracts from groups A, B and Y.
    Bisaillon JG; McSween G; Portelance V; Beaudet R; Morosoli R; Pouliot P; Micusan V
    Microbios; 1989; 60(244-245):193-208. PubMed ID: 2515422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Observations on the immune responses of infants and young children to group A meningococcal polysaccharide vaccine].
    Zhao JW
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Feb; 4(1):12-4. PubMed ID: 6411345
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunogenicity of in vitro folded outer membrane protein PorA of Neisseria meningitidis.
    Jansen C; Kuipers B; van der Biezen J; de Cock H; van der Ley P; Tommassen J
    FEMS Immunol Med Microbiol; 2000 Mar; 27(3):227-33. PubMed ID: 10683467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Humoral immune response to the capsular polysaccharide of Neisseria meningitidis serogroup C in an antimeningococcal BC vaccination trial in Antioquia, Colombia].
    Echeverry Uribe ML; Malberty Agüero JA; Galeano Marín LA; Sotolongo Padrón FT; Galguera Domínguez MA; Montoya Barrientos CM; Martínez Ruiz O; Nerey MC; Camarasa MA; Bacallao Gallestey J
    Bol Oficina Sanit Panam; 1995 Apr; 118(4):295-301. PubMed ID: 7779284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulin levels in malaria infected Nigerians with and without abnormal haemoglobin.
    Odegbemi JO; Williams AI
    Afr J Med Med Sci; 1995 Mar; 24(1):21-5. PubMed ID: 7495196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defences against meningococcal infections.
    Lancet; 1985 Oct; 2(8461):929-30. PubMed ID: 2865427
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.